These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2511706)

  • 41. Immune responses in Vietnamese children after a single dose of the auxotrophic, live Shigella flexneri Y vaccine strain SFL124.
    Li A; Cam PD; Islam D; Minh NB; Huan PT; Rong ZC; Karlsson K; Lindberg G; Lindberg AA
    J Infect; 1994 Jan; 28(1):11-23. PubMed ID: 8163828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Stimulation of the secretory IgA system in monkeys by parenteral immunization with a ribosomal Sonne dysentery vaccine].
    Dzhikidze EK; Stasilevich ZK; Salamatova SA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Sep; (9):66-70. PubMed ID: 2462772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The cellular and humoral immune response after administration to the guinea pig of Shigella flexneri 2a T32--Istrati vaccinal strain by different routes.
    Meitert T; Radu I; Ciudin L; Pencu E; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):267-76. PubMed ID: 395927
    [No Abstract]   [Full Text] [Related]  

  • 44. [Physico-chemical and immunobiological properties of the ribosomal preparations of Clostridium perfringens, type A].
    Efimova MG
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (2):46-9. PubMed ID: 9662798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The determination in saliva of IgA antibodies to Shigella ribosomes for the diagnosis of dysentery].
    Salamatova SA; Sukhoroslova LI; Chernokhvostova EV; Levenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jun; (6):59-62. PubMed ID: 1887713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Use of immunoenzyme analysis for evaluating the specificity of the antibody recognition of the antigenic determinants of Streptococcus group A].
    Shikhman AR
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul; (7):52-5. PubMed ID: 2413662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice.
    Farzam N; Ramon-Saraf R; Banet-Levi Y; Lerner-Geva L; Ashkenazi S; Kubler-Kielb J; Vinogradov E; Robbins JB; Schneerson R
    Vaccine; 2017 Sep; 35(37):4990-4996. PubMed ID: 28797729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Local Immune response in rabbits following enteral immunization with live attenuated bacterial Enterobacteriaceae vaccines].
    Dentschev W; Marinova S; Sumerska T; Nenkov P; Koitschev T; Trifonowa A
    Arch Exp Veterinarmed; 1980; 34(1):9-13. PubMed ID: 6998404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IpaD-loaded N-trimethyl Chitosan Nanoparticles Can Efficiently Protect Guinea Pigs against Shigella flexneri.
    Akbari MR; Saadati M; Honari H; Ghorbani HM
    Iran J Immunol; 2019 Sep; 16(3):212-224. PubMed ID: 31552830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Construction and characterization of virG (icsA)-deleted Escherichia coli K12-Shigella flexneri hybrid vaccine strains.
    Alexander WA; Hartman AB; Oaks EV; Venkatesan MM
    Vaccine; 1996 Aug; 14(11):1053-61. PubMed ID: 8879102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers.
    Kärnell A; Li A; Zhao CR; Karlsson K; Nguyen BM; Lindberg AA
    Vaccine; 1995 Jan; 13(1):88-99. PubMed ID: 7762285
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rough mutant of Shigella flexneri 2a that penetrates tissue culture cells but does not evoke keratoconjunctivitis in guinea pigs.
    Okamura N; Nakaya R
    Infect Immun; 1977 Jul; 17(1):4-8. PubMed ID: 328396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Construction and characterization of a live attenuated Shigella flexneri 2a vaccine strain, sf301 Delta virG and dsbA33G].
    Yang XF; Zhou L; Zheng J; Si LS; Wang YL
    Wei Sheng Wu Xue Bao; 2005 Oct; 45(5):748-52. PubMed ID: 16342769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. I. Construction of vaccine candidate strains with retained invasiveness but reduced intracellular multiplication.
    Linde K; Dentchev V; Bondarenko V; Marinova S; Randhagen B; Bratoyeva M; Tsvetanov Y; Romanova Y
    Vaccine; 1990 Feb; 8(1):25-9. PubMed ID: 2180230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Ribosomal dysentery vaccine. I. Method of production, physical and chemical properties].
    Levenson VI; Subbotina IuL; Gofman IL; Iarovaia LM
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Mar; (3):60-5. PubMed ID: 352058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Lipopolysaccharide changes in smooth-type avirulent Shigella in comparison with initial virulent strains].
    Nikolaeva AI; Nastichkin IA; Kabanova EA; Lapina EB; Krukovets IL
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):15-8. PubMed ID: 1441805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal Antibodies to Shigella Lipopolysaccharide Are Useful for Vaccine Production.
    Lin J; Smith MA; Benjamin WH; Kaminski RW; Wenzel H; Nahm MH
    Clin Vaccine Immunol; 2016 Aug; 23(8):681-8. PubMed ID: 27280622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Mechanism of the nonspecific protective action of Shigella antigens].
    Gorbunova ES; Elkina SI; Belina VB; Chekanova IuI; Vinogradov IV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):46-8. PubMed ID: 3046195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Live shigella flexneri 2a and shigella sonnei vaccines (author's transl)].
    Belaia IuA; Gekker VD; Kuz'min SN; Sergeeva NS
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):63-9. PubMed ID: 4216253
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunogenicity of the Shigella flexneri serotype Y (SFL 124) vaccine strain expressing cloned glucosyl transferase gene of converting bacteriophage SfX.
    Huan PT; Taylor R; Lindberg AA; Verma NK
    Microbiol Immunol; 1995; 39(7):467-72. PubMed ID: 8569531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.